These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8783497)

  • 1. The neglected role of type I interferon in the T-cell response: implications for its clinical use.
    Belardelli F; Gresser I
    Immunol Today; 1996 Aug; 17(8):369-72. PubMed ID: 8783497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease.
    Gibbert K; Dietze KK; Zelinskyy G; Lang KS; Barchet W; Kirschning CJ; Dittmer U
    J Immunol; 2010 Nov; 185(10):6179-89. PubMed ID: 20943997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
    Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
    Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-beta 2/interleukin 6 is a co-stimulant for human T lymphocytes.
    Tosato G; Pike SE
    J Immunol; 1988 Sep; 141(5):1556-62. PubMed ID: 2842397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.
    Peters M; Walling DM; Kelly K; Davis GL; Waggoner JG; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3147-52. PubMed ID: 3490513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine activation by interferon-gamma of STAT factors following T cell activation.
    Girdlestone J; Wing M
    Eur J Immunol; 1996 Mar; 26(3):704-9. PubMed ID: 8605941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
    Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
    J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation.
    Mullins DW; Koci MD; Burger CJ; Elgert KD
    Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):473-92. PubMed ID: 9805229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.
    Kronsteiner B; Wolbank S; Peterbauer A; Hackl C; Redl H; van Griensven M; Gabriel C
    Stem Cells Dev; 2011 Dec; 20(12):2115-26. PubMed ID: 21381973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer-helper effect of L cells in the generation of anti-MM cytotoxic T lymphocytes: replacement by beta-interferon and mechanisms of action.
    Ishikawa S; Tachibana T
    Jpn J Cancer Res; 1986 Sep; 77(9):931-40. PubMed ID: 2945807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interferon gamma on T lymphocytes from patients with multiple sclerosis.
    Grimaldi LM; Martino G
    Mult Scler; 1995; 1 Suppl 1():S38-43. PubMed ID: 9345397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-I-infected T cells evade the antiproliferative action of IFN-beta.
    Smith D; Buckle GJ; Hafler DA; Frank DA; Höllsberg P
    Virology; 1999 May; 257(2):314-21. PubMed ID: 10329542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity.
    Rizza P; Moretti F; Belardelli F
    Autoimmunity; 2010 Apr; 43(3):204-9. PubMed ID: 20187707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferons--biologic principles and clinical uses].
    Jacobsen H; Kirchner H
    Klin Padiatr; 1985; 197(4):263-7. PubMed ID: 3930830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I IFN substitutes for T cell help during viral infections.
    Wiesel M; Kratky W; Oxenius A
    J Immunol; 2011 Jan; 186(2):754-63. PubMed ID: 21160039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor T cell activation by human leukocyte interferon.
    Schnaper HW; Aune TM; Pierce CW
    J Immunol; 1983 Nov; 131(5):2301-6. PubMed ID: 6226738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma-Interferon plays a key role in T-cell-induced tumor regression.
    Tuttle TM; McCrady CW; Inge TH; Salour M; Bear HD
    Cancer Res; 1993 Feb; 53(4):833-9. PubMed ID: 8428364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
    Mizuguchi J; Takeuchi M; Usui M
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.